Learning and product entry: How diversification patterns differ over firm age and knowledge domains in U.S. generic drug industry

2013 ◽  
Vol 35 (3) ◽  
pp. 440-449 ◽  
Author(s):  
Xuanli Xie ◽  
Hugh M. O'Neill
Keyword(s):  
Generic Drug ◽  
Drug Industry ◽  
Firm Age ◽  
Knowledge Domains ◽  
Product Entry

Generic Drugs—A Look Back and a Look Ahead

1990 ◽  
Vol 3 (3) ◽  
pp. 192-202
Author(s):  
Leon Lachman ◽  
Salvatore Turco ◽  
James T. O'Donnell
Keyword(s):  
Generic Drug ◽  
Generic Drugs ◽  
Drug Industry ◽  
Look Ahead ◽  
Look Back

This review includes the viewpoints of three pharmaceutical scientists tracing the origins of the generic drug industry, examining the recent generic drug controversies, and offering suggestions to hospital practitioners for coping with the controversies.

The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging Patents

2018 ◽  
Vol 17 (1) ◽  
pp. 47-54 ◽  
Author(s):  
Jonathan J. Darrow ◽  
Reed F. Beall ◽  
Aaron S. Kesselheim
Keyword(s):  
Generic Drug ◽  
Drug Industry

Generic Drug Industry Dynamics

2005 ◽  
Vol 87 (1) ◽  
pp. 37-49 ◽  
Author(s):  
David Reiffen ◽  
Michael R. Ward
Keyword(s):  
Generic Drug ◽  
Drug Industry ◽  
Industry Dynamics

scholarly journals Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984

2013 ◽  
Vol 3 (5) ◽  
pp. 297-311 ◽  
Author(s):  
Garth Boehm ◽  
Lixin Yao ◽  
Liang Han ◽  
Qiang Zheng
Keyword(s):  
Generic Drug ◽  
Drug Industry ◽  
The Us

Entry Threats and Pricing in the Generic Drug Industry

2014 ◽  
Vol 96 (2) ◽  
pp. 214-228 ◽  
Author(s):  
Steven Tenn ◽  
Brett W Wendling
Keyword(s):  
Generic Drug ◽  
Drug Industry
Sign in / Sign up

Export Citation Format

Share Document